Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times
ICELLIS BIOREACTOR BACKGROUND In the past five years, Pall’s iCELLis bioreactor has emerged as the leading bioreactor technology for clinical and commercial manufacturing of viral vectors and vaccines, with the following data reported in peer- reviewed publications. Single-use, fixed-bed bioreactor Cell substrate composed of medical grade, uncoated, uncharged polyethylene teraphalate (PET) carriers Closed system with …